DCM
SION

Driehaus Capital Management’s Sionna Therapeutics SION Stock Holding History

Driehaus Capital Management’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Sell
76,633
-7,217
-9% -$275K 0.02% 295
2025
Q4 		$3.45M Hold
83,850
– – 0.02% 318
2025
Q3 		$2.47M Hold
83,850
– – 0.02% 341
2025
Q2 		$1.45M Sell
83,850
-245,039
-75% -$3.21M 0.01% 347
2025
Q1 		$3.44M Buy
+328,889
New +$5.37M 0.03% 311

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Driehaus Capital Management's SION Position: Q1 2026 in Review

Driehaus Capital Management reduced its Sionna Therapeutics (SION) stake by 8.6% in Q1 2026, selling an estimated $275K and leaving 76,633 shares worth $3.07M. The position accounts for 0.02% of the portfolio, ranked #295.

Driehaus Capital Management first reported a position in SION in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.45M in Q4 2025. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • Driehaus Capital Management held 76,633 shares of Sionna Therapeutics worth $3.07M as of Q1 2026.
  • Driehaus Capital Management sold 7,217 Sionna Therapeutics shares in Q1 2026, an estimated $275K.
  • Sionna Therapeutics made up 0.02% of Driehaus Capital Management's portfolio in Q1 2026, its #295 holding.
  • Driehaus Capital Management first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Driehaus Capital Management's Sionna Therapeutics position peaked at $3.45M in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.